Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

New Month, New Year, New Faculty, and New Baby
Author
Howard (Jack) West, MD

Happy new year to everyone, and with the change to January, there will again be some comings and goings of the faculty. I know I can speak for the entire GRACE community when I express my thanks to Dr. Pinder for her great help this past month, and we'll definitely have her back. Fortunately, Dr. Weiss has agreed to continue to participate in our discussions for January as well.

Also ringing in the new year with us will be some faculty who are coming back after relatively short or long absences. The ever-fabulous Dr. Stephanie Harman, head of the Palliative Care Program at Stanford University, is just coming off of maternity leave after having her first baby, Jack (I presume she didn't name him after me, but perhaps she does regard me that highly), in October, so I offer my congratulations and thanks for coming back to work with us while juggling home life and her return to regular work responsibilities.

Dr. Shirish Gadgeel is also a faculty member who has participated here and there in the past few years. He has written a few posts, now more than a year old (in our "classics" section) but was also kind enough to speak at our NSCLC Patient Education Forum in Seattle this past September on management principles for stage III NSCLC. He is a medical oncologist and lung cancer expert at the Barbara Ann Karmanos Cancer Center at Wayne State University in Detroit, and he has also been a friend in the field for many years. I'm very happy to have him participate on a more regular basis in the coming weeks.

I hope you'll find great discussions and valuable answers to your questions.

Next Previous link

Previous PostNext Post

Related Content

Image
Trial data ASCO 2024
Video
In this video series from ASCO 2024, Drs. Aakash Desai and Fauwzi Abu Rous discuss trial dates and clinical data as presented at the 2024 ASCO. To watch the complete playlist, click here.         
Image
Bladder Cancer Video Library 2024
Video
Dr. Petros Grivas discusses intravesical treatment for patients with nonmuscle invasive, or early-stage, bladder cancer, the importance of participating in clinical trials for bladder cancer, combination therapy options for patients with metastatic or incurable bladder cancer, and the importance of family history of cancer and discussing that history with your doctor.
Image
Case Based Panel
Video
The panel discusses treatment options for a patient diagnosed with EGFR Exon 19 Deletion NSCLC and examines data from the Laura Trial, a patient with a smoking history and diagnosis of small cell lung cancer, and how the Adriatic Study factors into decisions, and a patient with NSCLC adenocarcinoma, and a EGFR Exon 21 L858R Alteration, and how data from the Flaura 2 Trial can impact treatment decisions.

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on